Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

hs-CRP Is Associated With Incident Diabetic Nephropathy: Findings From the Jackson Heart Study.

Sinha SK, Nicholas SB, Sung JH, Correa A, Rajavashisth TB, Norris KC, Lee JE.

Diabetes Care. 2019 Nov;42(11):2083-2089. doi: 10.2337/dc18-2563. Epub 2019 Sep 11.

PMID:
31511234
2.

High-Sensitivity C-Reactive Protein Is Associated With Incident Type 2 Diabetes Among African Americans: The Jackson Heart Study.

Effoe VS, Correa A, Chen H, Lacy ME, Bertoni AG.

Diabetes Care. 2015 Sep;38(9):1694-700. doi: 10.2337/dc15-0221. Epub 2015 Jun 11.

3.

[High-sensitive C-reactive protein and Type 2 diabetic nephropathy].

Liao L, Lei MX, Chen HL, Wu J, Guo LJ.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2004 Dec;29(6):627-30. Chinese.

4.
5.

Renal and Cardiovascular Risk According to Tertiles of Urinary Albumin-to-Creatinine Ratio: The Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT).

Marcovecchio ML, Chiesa ST, Armitage J, Daneman D, Donaghue KC, Jones TW, Mahmud FH, Marshall SM, Neil HAW, Dalton RN, Deanfield J, Dunger DB; Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT) Study Group.

Diabetes Care. 2018 Sep;41(9):1963-1969. doi: 10.2337/dc18-1125. Epub 2018 Jul 19.

PMID:
30026334
6.

Serum high-sensitivity C-reactive protein levels are associated with high risk of development, not progression, of diabetic nephropathy among Japanese type 2 diabetic patients: a prospective cohort study (Diabetes Distress and Care Registry at Tenri [DDCRT7]).

Hayashino Y, Mashitani T, Tsujii S, Ishii H; Diabetes Distress and Care Registry at Tenri Study Group.

Diabetes Care. 2014 Nov;37(11):2947-52. doi: 10.2337/dc14-1357. Epub 2014 Aug 28.

PMID:
25168126
7.

Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients?

Wang AY, Woo J, Lam CW, Wang M, Sea MM, Lui SF, Li PK, Sanderson J.

J Am Soc Nephrol. 2003 Jul;14(7):1871-9.

8.

Association of serum high-sensitivity C-reactive protein with metabolic control and diabetic chronic vascular complications in patients with type 2 diabetes.

Chuengsamarn S, Rattanamongkolgul S, Sittithumcharee G, Jirawatnotai S.

Diabetes Metab Syndr. 2017 Apr - Jun;11(2):103-108. doi: 10.1016/j.dsx.2016.08.012. Epub 2016 Aug 22.

PMID:
27697536
9.

Serum Total Sialic Acid and Highly Sensitive C-reactive Protein: Prognostic Markers for the Diabetic Nephropathy.

Varma V, Varma M, Varma A, Kumar R, Bharosay A, Vyas S.

J Lab Physicians. 2016 Jan-Jun;8(1):25-9. doi: 10.4103/0974-2727.176230.

10.

[Association between high-sensitivity C-reactive protein and both cardiovascular, total mortality events in middle-aged Chinese adults].

Dong Y, Wang ZW, Wang X, Tian Y, Zhang LF, Chen Z, Cao HQ.

Zhonghua Liu Xing Bing Xue Za Zhi. 2018 Apr 10;39(4):428-432. doi: 10.3760/cma.j.issn.0254-6450.2018.04.008. Chinese.

PMID:
29699031
11.

Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality.

Parrinello CM, Lutsey PL, Ballantyne CM, Folsom AR, Pankow JS, Selvin E.

Am Heart J. 2015 Aug;170(2):380-9. doi: 10.1016/j.ahj.2015.04.017. Epub 2015 Apr 18.

12.

Statin therapy and risk of fracture: results from the JUPITER randomized clinical trial.

Peña JM, Aspberg S, MacFadyen J, Glynn RJ, Solomon DH, Ridker PM.

JAMA Intern Med. 2015 Feb;175(2):171-7. doi: 10.1001/jamainternmed.2014.6388.

13.

[Relationship between serum high-sensitivity C-reactive protein and obesity and impaired glycose metabolism in children and adolescents].

Yang SP, Gong CX, Cao BY, Yan C.

Zhonghua Er Ke Za Zhi. 2006 Dec;44(12):933-6. Chinese.

PMID:
17254464
14.

High-Sensitivity C-Reactive Protein and Risk of Stroke in Atrial Fibrillation (from the Reasons for Geographic and Racial Differences in Stroke Study).

Dawood FZ, Judd S, Howard VJ, Limdi NA, Meschia JF, Cushman M, Howard G, Herrington DM, Soliman EZ.

Am J Cardiol. 2016 Dec 15;118(12):1826-1830. doi: 10.1016/j.amjcard.2016.08.069. Epub 2016 Sep 14.

15.

Baseline high-sensitivity C-reactive protein predicts the risk of incident ankylosing spondylitis: Results of a community-based prospective study.

Su J, Cui L, Yang W, Shi H, Jin C, Shu R, Li H, Zeng X, Wu S, Gao X.

PLoS One. 2019 Feb 15;14(2):e0211946. doi: 10.1371/journal.pone.0211946. eCollection 2019.

16.

C-reactive protein predicts incident fracture in community-dwelling elderly Japanese women: the Muramatsu study.

Nakamura K, Saito T, Kobayashi R, Oshiki R, Oyama M, Nishiwaki T, Nashimoto M, Tsuchiya Y.

Osteoporos Int. 2011 Jul;22(7):2145-50. doi: 10.1007/s00198-010-1425-9. Epub 2010 Oct 9.

PMID:
20936400
17.

Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes.

Pu LJ, Lu L, Xu XW, Zhang RY, Zhang Q, Zhang JS, Hu J, Yang ZK, Ding FH, Chen QJ, Lou S, Shen J, Fang DH, Shen WF.

Cardiovasc Diabetol. 2006 Dec 20;5:27.

18.

High-Sensitivity Cardiac Troponin T (hs-cTnT) as a Predictor of Incident Diabetes in the Atherosclerosis Risk in Communities Study.

Whelton SP, McEvoy JW, Lazo M, Coresh J, Ballantyne CM, Selvin E.

Diabetes Care. 2017 Feb;40(2):261-269. doi: 10.2337/dc16-1541. Epub 2016 Nov 15.

19.

C-reactive protein and the risk of developing type 2 diabetes in Aboriginal Australians.

Wang Z, Hoy WE.

Diabetes Res Clin Pract. 2007 Apr;76(1):37-43. Epub 2006 Sep 6.

PMID:
16952410
20.

High-sensitivity C-reactive protein predicts mortality and technique failure in peritoneal dialysis patients.

Liu SH, Li YJ, Wu HH, Lee CC, Lin CY, Weng CH, Chen YC, Chang MY, Hsu HH, Fang JT, Hung CC, Yang CW, Tian YC.

PLoS One. 2014 Mar 25;9(3):e93063. doi: 10.1371/journal.pone.0093063. eCollection 2014.

Supplemental Content

Support Center